Showing results (221-230 of 288) with videos related to
Sort By:
Pageof 29
Journal of the American College of Cardiology|May 14, 2013
4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitationLaura Mauri, Elyse Foster, Donald D Glower, et al.Journal of Molecular Neuroscience : MN|June 21, 2022
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type AEmma Veronica Carsana, Giulia Lunghi, Simona Prioni, et al.Circulation|September 9, 2011
Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary interventionRobert W Yeh, Sharon-Lise T Normand, Robert E Wolf, et al.Journal of the American Heart Association|September 28, 2014
Clinical preventability of 30-day readmission after percutaneous coronary interventionJason H Wasfy, Jordan B Strom, Stephen W Waldo, et al.JACC. Cardiovascular Interventions|January 25, 2016
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI RegistrySiddharth A Wayangankar, Sripal Bangalore, Lisa A McCoy, et al.Circulation. Cardiovascular Quality and Outcomes|November 18, 2014
Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data RegistryRobert W Yeh, Matthew J Czarny, Sharon-Lise T Normand, et al.The American Journal of Cardiology|November 9, 2002
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized TrialLaura Mauri, Raoul Bonan, Bonnie H Weiner, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 11, 2018
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrestMaura Samarani, Nicoletta Loberto, Giulia Soldà, et al.JACC. Cardiovascular Interventions|May 26, 2009
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experienceSimon R Dixon, José P S Henriques, Laura Mauri, et al.Journal of Thrombosis and Thrombolysis|July 20, 2020
Biomarkers of platelet activation and cardiovascular risk in the DAPT trialDavid D Berg, Robert W Yeh, Laura Mauri, et al.Pageof 29